This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, R. K.
Right arrow Articles by Bloom, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, R. K.
Right arrow Articles by Bloom, D. C.

 Previous Article  |  Next Article 

Journal of Virology, March 2002, p. 2199-2205, Vol. 76, No. 5
0022-538X/02/$04.00+0     DOI: 10.1128/jvi.76.5.2199-2205.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Altering the Expression Kinetics of VP5 Results in Altered Virulence and Pathogenesis of Herpes Simplex Virus Type 1 in Mice

*** Robert K. Tran,1 Pauline T. Lieu,2,{dagger} Santiago Aguilar,2 Edward K. Wagner,2 and David C. Bloom1*

Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, Florida,1 Department of Molecular Biology and Biochemistry, University of California at Irvine, Irvine, California2

Received 30 August 2001/ Accepted 4 December 2001

While many herpes simplex virus (HSV) structural proteins are expressed with strict-late kinetics, the HSV virion protein 5 (VP5) is expressed as a "leaky-late" protein, such that appreciable amounts of VP5 are made prior to DNA replication. Our goal has been to determine if leaky-late expression of VP5 is a requirement for a normal HSV infection. It had been shown previously that recombinant viruses in which the VP5 promoter was replaced with promoters of other kinetic classes (including a strict late promoter) exhibited no alterations in replication kinetics or virus yields in vitro. In contrast, here we report that alterations in pathogenesis were observed when these recombinants were analyzed by experimental infection of mice. Following intracranial inoculation, a recombinant expressing VP5 from a strict-late promoter (UL38) exhibited an increased 50% lethal dose and a 10-fold decrease in virus yields in the central nervous system, while a recombinant expressing VP5 from an early (dUTPase) or another leaky-late (VP16) promoter exhibited wild-type neurovirulence. Moreover, following infection of the footpad, changing the expression kinetics of VP5 from leaky-late to strict-late resulted in 100-fold-less virus in the spinal ganglia during the acute infection than produced by either the parent virus or the rescued virus. These data indicate that the precise timing of appearance of the major capsid protein plays a role in the pathogenesis of HSV infections and that changing the expression kinetics has different effects in different cell types and tissues.

* Corresponding author. Mailing address: Department of Molecular Genetics & Microbiology, Box 100266, University of Florida College of Medicine, Gainesville, FL 32610-0266. Phone: (352) 392-8520. Fax: (352) 392-3133. E-mail: dbloom{at}ufl.edu.

{dagger} Present address: Invitrogen/Life Technologies, Carlsbad, CA 92008.

Journal of Virology, March 2002, p. 2199-2205, Vol. 76, No. 5
0022-538X/02/$04.00+0     DOI: 10.1128/jvi.76.5.2199-2205.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Liu, J., Lewin, A. S., Tuli, S. S., Ghivizzani, S. C., Schultz, G. S., Bloom, D. C. (2008). Reduction in Severity of a Herpes Simplex Virus Type 1 Murine Infection by Treatment with a Ribozyme Targeting the UL20 Gene RNA. J. Virol. 82: 7467-7474 [Abstract] [Full Text]  
  • Pesola, J. M., Coen, D. M. (2007). In vivo fitness and virulence of a drug-resistant herpes simplex virus 1 mutant. J. Gen. Virol. 88: 1410-1414 [Abstract] [Full Text]  
  • O'Neil, J. E., Loutsch, J. M., Aguilar, J. S., Hill, J. M., Wagner, E. K., Bloom, D. C. (2004). Wide Variations in Herpes Simplex Virus Type 1 Inoculum Dose and Latency-Associated Transcript Expression Phenotype Do Not Alter the Establishment of Latency in the Rabbit Eye Model. J. Virol. 78: 5038-5044 [Abstract] [Full Text]  
  • Pearson, A., Knipe, D. M., Coen, D. M. (2004). ICP27 Selectively Regulates the Cytoplasmic Localization of a Subset of Viral Transcripts in Herpes Simplex Virus Type 1-Infected Cells. J. Virol. 78: 23-32 [Abstract] [Full Text]  
  • Brandt, C. R., Kolb, A. W. (2003). Tyrosine 116 of the Herpes Simplex Virus Type 1 IE{alpha}22 Protein Is an Ocular Virulence Determinant and Potential Phosphorylation Site. IOVS 44: 4601-4607 [Abstract] [Full Text]  
  • Brandt, C. R., Kolb, A. W., Shah, D. D., Pumfery, A. M., Kintner, R. L., Jaehnig, E., Van Gompel, J. J. (2003). Multiple Determinants Contribute to the Virulence of HSV Ocular and CNS Infection and Identification of Serine 34 of the US1 Gene as an Ocular Disease Determinant. IOVS 44: 2657-2668 [Abstract] [Full Text]  
  • Luker, G. D., Bardill, J. P., Prior, J. L., Pica, C. M., Piwnica-Worms, D., Leib, D. A. (2002). Noninvasive Bioluminescence Imaging of Herpes Simplex Virus Type 1 Infection and Therapy in Living Mice. J. Virol. 76: 12149-12161 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»